I help procurement, category management and commercial teams make faster sourcing decisions — building market sizing models, supplier landscapes, cost benchmarks and scopes of work across clinical, patient-services and consumer-health categories.
Six recurring workstreams across the engagements in my research library.
TAM/SAM/SOM builds, regional splits and CAGR forecasts using primary + secondary triangulation.
Long-list to short-list supplier mapping with operational, geographic and functional capability scoring.
Porter's Five Forces, SWOT and negotiation-leverage assessments built for category strategy decks.
Cost-structure breakdowns and category-specific savings levers with implementation risk flags.
Procurement-ready SOWs — objectives, actionables, timelines and project teams — for sourcing engagements.
Independent research on emerging consumer-health categories, from demographics to channel economics.
10 category intelligence reports from my research library. Ask for a full sample deck on any category below.
Mapped the HUB-support landscape — single-point-of-contact services connecting rare-disease and high-cost-therapy patients to manufacturers, physicians and payers — covering demand drivers, negotiation leverage and supplier shortlisting.
Two linked studies on financial-assistance categories — patient assistance programs and copay-card services — benchmarking supplier models, accumulator/maximizer policy shifts and enrollment-technology trends shaping vendor selection.
Evaluated the adherence-technology supplier space — smart packaging, reminder platforms and counselling services — with a competitive landscape review and a case study on a leading adherence-program vendor.
Sized the North American specialty-infusion market and benchmarked a 45+ supplier landscape spanning CROs and niche infusion specialists, with recommendations tied to home-based and outpatient care growth.
Assessed comparator-sourcing channels and Expanded Access Program (EAP) capability tiers under the 21st Century Cures Act, segmenting the supplier base into full-service, mid-tier and logistics-only specialists.
Applied a structured Define–Size–Benchmark framework to the global lab supplies/equipment category, including supplier M&A tracking, a best-practice matrix and a Porter's Five Forces read on buyer leverage.
Authored formal SOWs translating procurement objectives into optimization parameters, business questions and actionables — covering market analysis, supplier identification/capability mapping, timelines and project governance.
Identified savings levers across lab asset management (supply-base consolidation, lifecycle management, procurement optimization) and patient recruitment & retention (digital recruitment, decentralized trials, wearables), each scored for savings potential and implementation risk.
Two self-initiated studies on the medical and cosmetic pedicure/podiatry space — cost structures, clientele demographics, salon density by state and awareness of podiatric foot care.
Built structured supplier-selection workbooks — research methodology, selection criteria and long-lists — for specialty diagnostics and home-healthcare-nursing categories, scored on operational, geographic and functional fit.
The same five-step framework runs under every engagement above.
Scope, sub-services and buyer decision factors.
TAM/SAM/SOM, regional split, forecast horizon.
Cost structure, drivers/constraints, SWOT, Porter's.
Long-list → capability scoring → short-list.
Negotiation leverage, sourcing strategy, next steps.
A lean, senior-led practice — no junior pass-through, no templated output.
I am an independent market research consultant specializing in the pharmaceutical, biotech, and healthcare sectors. I partner with organizations — from global pharmaceutical companies and medical device manufacturers to private equity funds and specialist consultancies — to deliver rigorous, decision-ready market intelligence.
My research combines primary fieldwork — executive interviews, expert panels, payer surveys — with deep secondary analysis of regulatory databases, clinical registries, company filings, and reimbursement policy sources. Every study is built to answer a specific strategic question, not to produce a generic market report.
Unice Research operates as a lean, senior-led practice: no junior pass-through, no templated output. Every client works directly with me from scoping through delivery.
Whether you have a well-defined research brief or an early-stage strategic question, I'm happy to discuss scope, timelines and budget. Initial consultations are always complimentary.